Related Experiment Video
Updated: May 9, 2026

Quantification of Monocyte Transmigration and Foam Cell Formation from Individuals with Chronic Inflammatory Conditions
Published on: October 17, 2017
Monocyte heterogeneity in cardiovascular disease
Peter Libby1, Matthias Nahrendorf, Filip K Swirski
1Division of Cardiovascular Medicine, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, 77 Avenue Louis Pasteur, Boston, MA, 02115, USA. plibby@rics.bwh.harvard.edu
Inflammation and immunity play key roles in cardiovascular diseases like myocardial infarction and atherosclerosis. This review highlights the critical functions of innate immunity, particularly mononuclear phagocytes, in these conditions.
Area of Science:
- Cardiovascular Pathophysiology
- Immunology
- Inflammation
Background:
- Historically, inflammation and immunity were overlooked in cardiovascular disease research.
- Emerging evidence confirms the involvement of innate and adaptive immunity in cardiovascular conditions.
- This intersection is a rapidly growing area of scientific interest.
Purpose of the Study:
- To review the contribution of innate immunity to cardiovascular pathophysiology.
- To focus on acute cardiac injury (myocardial infarction) and chronic arterial inflammation (atherosclerosis).
- To examine the role of mononuclear phagocytes and their subsets in cardiovascular diseases.
Main Methods:
- Literature review focusing on innate immunity in cardiovascular diseases.
- Analysis of existing data on mononuclear phagocyte function.
- Emphasis on emerging research regarding immune cell subsets.
Main Results:
- Innate immunity significantly contributes to myocardial infarction pathogenesis.
- Innate immune responses are central to the development of atherosclerosis.
- Specific functional subsets of mononuclear phagocytes play distinct roles in cardiovascular pathophysiology.
Conclusions:
- Innate immunity is a critical factor in both acute and chronic cardiovascular diseases.
- Understanding mononuclear phagocyte subsets offers new therapeutic targets.
- Further research into immune mechanisms is essential for advancing cardiovascular medicine.
Related Concept Videos
Coronary Artery Disease II: Pathophysiology
Differentiation of Common Myeloid Progenitor Cells
Cardiomyopathy I: Introduction and Classification

